Q3 2025 El En SpA Earnings Call Transcript

Nov 17, 2025 / 10:59 AM GMT
Release Date Price: $12.52

Key Points

Positve
  • El.En. SpA (LTS:0RH2) reported strong profitability in Q3 2025, particularly in the medical sector.
  • Revenues in the medical sector increased by 4.6% over nine months, with a potential growth of 7.1% excluding the exit of the Japanese subsidiary.
  • The company achieved higher margins in the medical sector due to increased sales in high-margin segments like anti-aging treatments.
  • The surgical business, especially in urology, showed significant growth, with laser systems revenue up by 7.5%.
  • Cash generation was robust, with a net financial position increase of €47 million in Q3, partly due to the sale of a majority stake in Pentalis.
Negative
  • Consolidated EBIT was down 3.2% over nine months, despite a recovery in Q3.
  • The industrial business underperformed, with revenues and profits not meeting expectations.
  • The cutting business faced delays in revenue recognition due to late order bookings and delivery lead times.
  • The industrial division's performance was weak, particularly in laser marketing systems for special applications.
  • The company faced challenges in the US market due to the potential acquisition by a Chinese entity, affecting customer confidence.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ELEN.MI - El En SpA
Q3 2025 El En SpA Earnings Call
Nov 17, 2025 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay, good afternoon or good morning to everyone and welcome to Ellen's 3rd Q2025 financial results conference call. Today's call will be recorded and there will be an opportunity for questions at the end of the call with me on the call, Andre.

Canjoli, AllN CEO, and Enrico Romagnoli, Alliance, Chief Financial Officer and investor relator manager.

Before we begin, please note that there are management remarks during the conference call regarding future expectations, plans, prospects, and for looking set.

Certain statements in this call, including those addressing to the company beliefs, plans, objective, estimates, or expectation of a possible future results or events are forward-looking statements. Forward-looking statements
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot